Kezar Life Sciences, Inc. (KZR) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts KZR Hot Sheet
Join SI Premium – FREE
Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q2 EPS of ($0.34), $0.02 worse than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Flowserve acquires Trillium valves division for $490 million
- Corona-maker Constellation Brands beats estimates, shares jump 2%
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
